{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-043448","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2023-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.635824+00:00","generated_at":"2026-06-10T21:43:45.183313+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Roivant completes redemption of outstanding warrants; most exercised for shares","bullets":["20,061,507 public warrants exercised cashless for 5,005,531 common shares; 397 exercised for cash at $11.50.","All private warrants exercised cashless for 2,548,621 common shares.","Redemption price was $0.10 per warrant; warrants delisted from Nasdaq.","Common shares continue trading under ROIV on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-043448","json":"https://secwatch.observer/filing/0001140361-23-043448.json","markdown":"https://secwatch.observer/filing/0001140361-23-043448.md","text":"https://secwatch.observer/filing/0001140361-23-043448.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043448/0001140361-23-043448-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036123043448/brhc20058679_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T21:43:45.183313+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}